2 studies found for:    301762 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia
Condition: Leukemia, Adult T-Cell
Intervention: Biological: Denileukin diftitox (Ontak)
2 Completed Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1
Condition: Human T-Lymphoma Virus Type I
Intervention:

Indicates status has not been verified in more than two years